4:07 PM ET
10-Q
Financial Results
enVVeno Medical Q3 2026 Results: Net Loss of $4.37M, Loss Narrows
enVVeno Medical Corp reported a net loss of $11.8 million for the first nine months of 2026, an improvement from the $15.7 million loss in the prior year period. The company is transitioning into a pivotal U.S. clinical study for its enVVe System after receiving FDA IDE approval in April 2026.
- Key figure
- Net loss $4.37M